Literature DB >> 18595663

Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: a video-EEG study.

Johanna Palmio1, Tapani Keränen, Tiina Alapirtti, Janne Hulkkonen, Riikka Mäkinen, Päivi Holm, Jaana Suhonen, Jukka Peltola.   

Abstract

Established markers of brain damage, neuron-specific enolase (NSE) and S-100b protein (S-100), may increase after status epilepticus, but whether a single tonic-clonic or complex partial seizure induces elevation of these markers is not known. Furthermore, it is unclear whether the risk of seizure-related neuronal damage in temporal lobe epilepsy (TLE) differs from that in extratemporal lobe epilepsies (XTLE). The aim of this study was to analyze NSE and S-100 in patients with TLE and XTLE after acute seizures. The levels of NSE and S-100 were measured in serum before (0h) and at 3, 6, 12, and 24h after acute seizures in 31 patients during inpatient video-EEG monitoring. The patients were categorized into the TLE and the XTLE group based on video-EEG recordings and MRI findings. Fifteen patients had TLE and 16 XTLE. Index seizures were mainly complex partial seizures (n=21). In TLE mean+/-S.D. values for NSE levels (mug/L) were 8.36+/-2.64 (0h), 11.35+/-3.84 (3h), 13.48+/-4.49 (6h), 12.95+/-5.46 (12h) and 10.33+/-3.13 (24h) (p=0.006, ANOVA). In XTLE the changes were not significant (p=0.3). There was less increase in the levels of S-100 in TLE (p=0.05) and no significant change in XTLE (p=0.4). The levels of markers of neuronal damage were increased in patients with TLE, not only after tonic-clonic but also after complex partial seizures. These data suggest that TLE may be associated with brain damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595663     DOI: 10.1016/j.eplepsyres.2008.05.006

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  6 in total

1.  The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant Epilepsy.

Authors:  John R Pollard; Ofer Eidelman; Gregory P Mueller; Clifton L Dalgard; Peter B Crino; Christopher T Anderson; Elizabeth J Brand; Evren Burakgazi; Sai K Ivaturi; Harvey B Pollard
Journal:  Front Neurol       Date:  2013-01-03       Impact factor: 4.003

2.  Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy.

Authors:  Chiung-Chih Chang; Chun-Chung Lui; Chen-Chang Lee; Shang-Der Chen; Wen-Neng Chang; Cheng-Hsien Lu; Nai-Ching Chen; Alice Y W Chang; Samuel H H Chan; Yao-Chung Chuang
Journal:  BMC Neurol       Date:  2012-03-14       Impact factor: 2.474

3.  Transcranial photobiomodulation (808 nm) attenuates pentylenetetrazole-induced seizures by suppressing hippocampal neuroinflammation, astrogliosis, and microgliosis in peripubertal rats.

Authors:  Chung-Min Tsai; Shwu-Fen Chang; Chih-Chuan Li; Hsi Chang
Journal:  Neurophotonics       Date:  2022-03-25       Impact factor: 4.212

4.  A Meta-Analysis of Neuron-Specific Enolase Levels in Cerebrospinal Fluid and Serum in Children With Epilepsy.

Authors:  Rong-Zheng Mu; Shuang Liu; Kai-Ge Liang; Dan Jiang; Yao-Jiang Huang
Journal:  Front Mol Neurosci       Date:  2020-03-10       Impact factor: 5.639

Review 5.  Nonconvulsive seizures and nonconvulsive status epilepticus in the neuro ICU should or should not be treated aggressively: A debate.

Authors:  Andrea O Rossetti; Lawrence J Hirsch; Frank W Drislane
Journal:  Clin Neurophysiol Pract       Date:  2019-08-09

6.  Peripheral Blood and Salivary Biomarkers of Blood-Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts.

Authors:  Damir Janigro; Damian M Bailey; Sylvain Lehmann; Jerome Badaut; Robin O'Flynn; Christophe Hirtz; Nicola Marchi
Journal:  Front Neurol       Date:  2021-02-04       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.